Development of plasmid-mediated resistance in Vibrio cholerae during treatment with trimethoprim-sulfamethoxazole.
AUTOR(ES)
Dupont, M J
RESUMO
The persistence of Vibrio cholerae, biotype el tor, in a patient treated with trimethoprim-sulfamethoxazole was due to the acquisition of a conjugative resistance plasmid. The plasmid, with a molecular size of 72 megadaltons, belonged to incompatibility group 6-C and conferred resistance to ampicillin, chloramphenicol, sulfonamide, and trimethoprim.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=176256Documentos Relacionados
- Plasmid-Mediated Resistance to Trimethoprim-Sulfamethoxazole in Salmonella krefeld Strains Isolated in the United States
- Plasmid-mediated changes in virulence of Vibrio cholerae.
- Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
- Aseptic meningitis due to trimethoprim-sulfamethoxazole.
- Treatment of complicated urinary tract infections with lomefloxacin compared with that with trimethoprim-sulfamethoxazole.
